Stay updated on Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial page.

Latest updates to the Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial page
- Check7 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.0%
- Check14 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check22 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.8%
- Check29 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.1%
- Check50 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check58 days agoChange DetectedThe webpage has added a section with helpful links provided by Pfizer, which includes information on how to obtain contact details for a study center nearby.SummaryDifference0.4%
Stay in the know with updates to Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial page.